Appropriations Negotiators Allow NIH Translational Science Center Launch
This article was originally published in The Tan Sheet
Executive Summary
NIH receives more than $500 million to finance the National Center for Advancing Translational Science, created in the consolidated fiscal 2012 appropriations bill. Members of Congress cautioned that NCATS’ work to speed up drug development should not inhibit private efforts in the same arena.
You may also be interested in...
ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment
Proposed Advanced Research Project Agency for Health also needs to distinguish itself from NCATS, which faced many of the same questions when it was created a decade ago. Disagreements also persist about whether ARPA-H should be housed in NIH or HHS.
FDA, NIH Devise Regulatory Research Agenda, Look For Financing
The budget sequester is making it difficult to fund new projects, “no matter how high a priority,” National Center for Advancing Translational Sciences Director Christopher Austin notes. The Institute of Medicine recommends more collaborations to strengthen the Clinical and Translational Science Awards program.
FDA, NIH Devise Regulatory Research Agenda, Look For Financing
The budget sequester is making it difficult to fund new projects, “no matter how high a priority,” National Center for Advancing Translational Sciences Director Christopher Austin notes. The Institute of Medicine recommends more collaborations to strengthen the Clinical and Translational Science Awards program.